Eucalyptus Ltd., Hebrew University of Jerusalem deal

The university's Yissum Research and Development Co. granted Eucalyptus exclusive, worldwide rights to N-acetylcysteine amide (AD4) to treat and prevent neurodegenerative diseases. The antioxidant is ...